According to a recent market study published by Growth Market Reports titled, “Global Single Blood Drop Analysis Market by Type, Application, End-user, and Regions: Size, Share, Trends, and Opportunity Analysis, 2017-2027”, the market was valued at USD 18,412.6 Million in 2019 and is expected to expand at a CAGR of 11.5% during the forecast period. In terms of volume the single blood drop analysis market is anticipated to expand at a CAGR of 11.0% during the forecast period.

The global single blood drop analysis market is anticipated to grow, owing to upsurge in the prevalence of the diabetes, cancer, and corona virus across the globe, which has led to the rise in the adoption of the single blood drop analysis. Single blood drop analysis is performed by finger prick and the capillary puncture method. Single blood drop analysis is often used in the healthcare industry to determine biochemical and physiological factors, such as mineral content, disease, organ function, and drug effectiveness. Single blood drop analysis is an inexpensive and a rapid technique that allows healthcare professionals to access different viruses that have infected patients. The new generation single blood drop diagnostic test allows the detecting of serious diseases from diabetes and cancer to heart diseases. The results of single blood drop analysis are faster, more precise, less painful, and less expensive than conventional blood collection methods.

Request a free sample copy: https://growthmarketreports.com/request-sample/210

The global single blood drop analysis market is fragmented based on type, applications, end-users. Based on type, the global single blood drop analysis market is divided into blood collection, blood analyzers, and consumables. The blood collection segment is projected to account for a substantial share of the market during the forecast period owing to increasing disease prevalence across the globe. Blood collection segment is further bifurcated into finger prick, capillary blood collection, and intravenous blood collection method. Blood analyzers market is further segmented into point of care blood analyzers, and lab-based blood analyzers. The consumables are further segmented into, reagents & assays, and disposable kits. Based on applications, the global single blood drop analysis market is divided into cancer, diabetics, cardiovascular, viral/bacterial infection, fertility, and allergy. The diabetics segment is anticipated to hold a significant share of the single blood drop analysis market during the forecast period. This growth may be attributed to the increasing prevalence of diabetics across the globe. Based on end-users, the global single blood drop analysis market is divided into hospitals, clinics, home, and others. The home segment is anticipated to grow during the forecast period owing to growing popularity of home diagnostics and e-healthcare services across the globe. Increasing requirement for accurate, rapid, and inexpensive disease diagnostics in various clinical settings is a prominent trend, which is projected to drive the clinics segment.

Based on regions, the global single blood drop analysis market is classified as Europe, North America, Asia Pacific, Latin America, and Middle East & Africa. The Europe region is categorized as the Germany, France, Italy, U.K., Spain, Russia, Rest of Europe. North America is bifurcated into countries such as the US and Canada. Latin America is categorized as Brazil, Mexico, Rest of Latin America (LATAM). Asia Pacific is split into countries, China, Japan, South Korea, India, Australia, South East Asia (SEA), and Rest of Asia Pacific (APAC), while the MEA is divided into Saudi Arabia, South Africa, UAE, and Rest of Middle East & Africa (MEA). North America accounts for a significant share of the market, followed by Europe. The market in Asia Pacific is projected to expand at a significant CAGR during the forecast period. The single blood drop analysis market in North America is projected to grow due to the presence of established market players in the region who are frequently developing and introducing novel products. The growth of the market in Asia Pacific is attributed to the substantial rise in number of research & development facilities pertaining to single blood drop collection in China, India, and Australia. Moreover, rising presence of several biotechnology companies in Asia Pacific is expected to boost the demand for single blood drop analysis products in the region.

In year 2020, the single blood drop analysis market is expected to witness the significant growth due to COVID-19 pandemic. The outbreak has led to the rise in the adoption of single blood drop testing devices, for the analysis of COVID-19 during this pandemic. This is impacting the demand for single blood drop analysis products. Thus, it is anticipated to create lucrative opportunity for single blood drop analysis manufacturers during this pandemic situation.

As per Growth Market Reports industry analyst Akshata Ahire, “The Global Single Blood Drop Analysis Market is anticipated to expand at significant pace during the forecast period, from 2020 to 2027. The market is driven by the Increasing demand for self-monitoring diagnostic devices, growing number of patients with diabetic and cardiovascular disorders and other factors.”

Key Takeaways from the Study:

  • North America accounts for a significant share of the market, followed by Europe. The market in Asia Pacific is projected to expand at significant CAGR during the forecast period
  • In terms of value, the blood collection segment is projected to increase at a substantial CAGR during the forecast timeline

Report Scope:

Report Metric

Details

Market Value in 2019

USD 18,412.6 Million

Market Growth Rate (from 2020 to 2027)

11.5%

Historical Data

2017 & 2018

Base Year

2019

Forecast Period

2020 - 2027

Units Considered

Value (USD Million)

Market Segments

Type, Applications, and End-users

Regional Scope

North America, Europe, Latin America, Asia Pacific, and Middle East & Africa (MEA)

Country Scope

US, Canada, Brazil, Mexico, Rest of Latin America, India, China, Japan, South Korea, Australia, South East Asia, Rest of Asia Pacific, the UK, France, Germany, Italy, Spain, Russia, Rest of Europe, Saudi Arabia, South Africa, the UAE, and Rest of MEA.

Key Companies Profiled

Danaher Corporation, Siemens,, Bayer AG,
Roche Holding AG, Abbott Laboratories, BluSense Diagnostics, Jana Care Inc., Eurolyser Diagnostica GmbH, Genalyte, Abionic SA, Becton, Dickinson and Company, Grail Inc. and Karius Inc.

Customization Scope

Report customization available on request

Pricing and Purchase Options

Avail tailor-made purchase options to meet your research requirements

Target Audience:

  • Supply-side: Single blood drop analysis manufacturers, raw material suppliers, and distributors
  • Demand Side: Hospitals, home, healthcare technicians, diagnostic centers, academic and research institutes
  • Regulatory Side: Concerned government authorities, government agencies, and other regulatory bodies
  • Associations and Industry Bodies: Food and Drugs Administration, Code of Federal Regulations, American Association of Pharmaceutical Scientists, International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use, American Cancer Society, American Association for Clinical Chemistry, Toxic Substances Control Act (TSCA), Diabetes Technology Society, World Health Organization and others.